Edition:
United States

Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
1:33pm EDT
Change (% chg)

$-0.02 (-1.14%)
Prev Close
$1.75
Open
$1.75
Day's High
$1.76
Day's Low
$1.71
Volume
20,202
Avg. Vol
90,194
52-wk High
$14.85
52-wk Low
$1.58

Chart for

About

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuti... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $299.86
Shares Outstanding(Mil.): 171.35
Dividend: --
Yield (%): --

Financials

  JAGX.OQ Industry Sector
P/E (TTM): -- 240.92 34.18
EPS (TTM): -4.96 -- --
ROI: -127.39 -5.87 13.17
ROE: -323.22 -7.71 15.15

BRIEF-Jaguar Health Files For Resale Of Up To 29.4 Mln Shares Common Stock By The Selling Shareholders

* JAGUAR HEALTH INC FILES FOR RESALE OF UP TO 29.4 MILLION SHARES COMMON STOCK BY THE SELLING SHAREHOLDERS - SEC FILING Source : https://bit.ly/2qOl6Fa Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 20 2018

BRIEF-Jaguar Health Says Unit Signed Agreement With ADAP Crisis Task Force

* JAGUAR INC SAYS NAPO PHARMACEUTICALS HAS SIGNED AN AGREEMENT WITH ADAP CRISIS TASK FORCE

Apr 10 2018

BRIEF-Jaguar Health Inc Files For Non-Timely 10-K With U.S. SEC

* JAGUAR HEALTH INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2GQ2TRx) Further company coverage:

Apr 02 2018

BRIEF-Jaguar Health Says Entered Securities Purchase Agreement With Chicago Venture Partners - SEC Filing​

* JAGUAR HEALTH - ‍ON FEB 26, CO ENTERED SECURITIES PURCHASE AGREEMENT WITH CHICAGO VENTURE PARTNERS - SEC FILING​

Mar 02 2018

BRIEF-Jaguar Health Says Unit Napo Pharmaceuticals Signs Deal With Transition Patient Services To Establish Nationwide Pilot "Mytesi Direct" Program

* JAGUAR HEALTH - UNIT NAPO PHARMACEUTICALS SIGNS DEAL WITH TRANSITION PATIENT SERVICES TO ESTABLISH NATIONWIDE PILOT “MYTESI DIRECT” PROGRAM

Mar 02 2018

BRIEF-Jaguar Health Files For Resale Or Other Disposition Of Up To 6.02 Mln Shares Of Voting Common Stock

* JAGUAR HEALTH INC FILES FOR RESALE OR OTHER DISPOSITION OF UP TO 6.02 MILLION SHARES OF VOTING COMMON STOCK - SEC FILING Source text: [http://bit.ly/2BJoioW] Further company coverage:

Jan 31 2018

BRIEF-Jaguar Health Provides Updates Regarding Programs

* JAGUAR HEALTH PROVIDES UPDATES REGARDING COMMERCIAL, EDUCATIONAL & PRODUCT DEVELOPMENT PROGRAMS AND 2017 RESULTS FOR MYTESI SINCE MERGER (AUGUST–DECEMBER 2017) Source text for Eikon: Further company coverage:

Jan 22 2018

BRIEF-Jaguar Health Says Unit Entered Amendment To Note Purchase Agreement

* JAGUAR HEALTH - ON DEC 29, 2017, UNIT ENTERED AMENDMENT TO NOTE PURCHASE AGREEMENT & NOTES WITH EACH OF PURCHASERS PARTY TO AGREEMENT DATED MARCH 1, 2017

Jan 02 2018

Earnings vs. Estimates